• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human SH2 domain-containing protein 3A (SH2D3A)

ACP11094

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP11094 Target NameSH2D3A
Target SynonymsNovel SH2 containing protein 1 ; Novel SH2-containing protein 1; NSP1; SH2 domain containing 3A; SH2 domain containing protein 3A; SH2 domain-containing protein 3A; SH23A_HUMAN; SH2D3AFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-576
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9BRG2
Background Information
  • Uniprot Id

    Q9BRG2

  • Target Species

    Human

  • Target Name

    SH2D3A

  • Target Full Name

    SH2 domain-containing protein 3A

  • Target Function

    May play a role in JNK activation.

  • Target Tissue Specificity

    Weakly expressed in placenta, fetal kidney, fetal lung, adult pancreas, adult kidney and adult lung.

  • Target Synonyms

    Novel SH2 containing protein 1 ; Novel SH2-containing protein 1; NSP1; SH2 domain containing 3A; SH2 domain containing protein 3A; SH2 domain-containing protein 3A; SH23A_HUMAN; SH2D3A

  • Target Background

    Predicted to enable guanyl-nucleotide exchange factor activity and phosphotyrosine residue binding activity. Predicted to be involved in positive regulation of peptidyl-serine phosphorylation.

Inquire Recombinant Human SH2 domain-containing protein 3A (SH2D3A) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification